Loading...
Sponsoring organization: American College of Physicians (ACP)
Target Population: Primary care physicians, cardiologists
Treatments for anemia in patients with heart disease include erythropoiesis-stimulating agents (ESAs), red blood cell (RBC) transfusions, and iron replacement, but whether these treatments improve outcomes is unclear. The ACP's new guideline is based on a systematic review of evidence on benefits and harms of these treatments in patients with congestive heart failure (CHF) or coronary heart disease (CHD).
— Treatment with RBC transfusions (low-quality evidence)
No short-term mortality benefit was found for liberal RBC transfusion versus more restrictive transfusion (hemoglobin trigger leve…